Stat3-siRNA Induces Fas-Mediated Apoptosis in Vitro and in Vivo in Breast Cancer

International Journal of Oncology - Greece
doi 10.3892/ijo_00000249
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

Transfer of siRNA Against XIAP Induces Apoptosis and Reduces Tumor Cells Growth Potential in Human Breast Cancer in Vitro and in Vivo

Breast Cancer Research and Treatment
Cancer ResearchOncology
2007English

Goyazensolide Induces Apoptosis in Cancer Cells in Vitro and in Vivo

International Journal of Cancer Research
Cancer ResearchOncology
2013English

Quinalizarin Induces ROS‑mediated Apoptosis via the MAPK, STAT3 and NF‑κB Signaling Pathways in Human Breast Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

A Selective Defect in Fas-Mediated Apoptosis in HAM/TSP: An Ex Vivo, in Vitro and in Silico Study

Retrovirology
VirologyInfectious Diseases
2014English

Pristimerin Induces Apoptosis and Autophagy via Activation of ROS/ASK1/JNK Pathway in Human Breast Cancer in Vitro and in Vivo

Cell Death Discovery
Cancer ResearchMolecular NeuroscienceImmunologyCell BiologyCellular
2019English

MicroRNA 196B Regulates FAS-mediated Apoptosis in Colorectal Cancer Cells

Oncotarget
Oncology
2015English

Lidocaine Induces Endoplasmic Reticulum Stress-Associated Apoptosis in Vitro and in Vivo

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2011English

Rhein Induces Apoptosis in Human Breast Cancer Cells

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2012English

Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes in Vitro and in Vivo

Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy